文献速递前列腺癌

优化前列腺磁共振成像融合靶向穿刺活检中靶向穿刺针数

Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
PubMed 文献 · Eur Urol Oncol · 2018-10-05

该回顾性队列研究纳入2015至2017年接受MRI-超声融合靶向活检的479例患者共615个ROI,每个ROI取4针。结果显示前两针可代表88.4%的最高Gleason核心和88.9%的临床显著癌核心,PI-RADS 5分独立预测最高Gleason核心出现在第3针以后,但仍有部分患者可从额外穿刺针中获益。

要点

  • 前两针覆盖88.4%的最高Gleason核心和88.9%的临床显著癌核心。
  • PI-RADS 5分独立预测最高Gleason核心出现在第3针及以后。
  • 多数癌症前两针即可充分表征,但部分患者仍可从额外穿刺针获益。

核心结论

  • 第1-2针在88.4%的情况下代表最高Gleason核心,在88.9%的情况下代表临床显著癌核心。
  • PI-RADS 5分独立预测最高Gleason核心出现在第3针及以后。
  • 多数癌症在前两针活检中得到了适当表征,但仍有部分男性可从额外穿刺针中获益。

研究设计与样本

  • 回顾性队列研究,纳入2015年至2017年接受MRI-超声融合靶向活检的479例患者,共615个ROI,每个ROI取4针。

主要发现

  • 在任意癌症患者中,最高Gleason核心位于第1、2、3、4针的人数分别为477例(76.8%)、69例(11.6%)、48例(7.6%)、24例(4.0%)。
  • 在临床显著癌患者中,首个临床显著癌核心位于第1、2、3、4针的样本数分别为191例(77.8%)、26例(11.1%)、17例(6.2%)、11例(4.9%)。
  • 与PI-RADS 5分相比,PI-RADS 4分(OR 0.287;p=0.006)、PI-RADS 3分(OR 0.284;p=0.006)、PI-RADS 2分(OR 0.343;p=0.015)的患者出现最高Gleason核心在第3针及以后的可能性显著更低。

关键数值与推荐

  • 前两针代表最高Gleason核心的比例为88.4%,代表临床显著癌核心的比例为88.9%。
  • PI-RADS 5分独立预测最高Gleason核心出现在第3针及以后。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究局限性包括单中心经验和回顾性性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of prostate biopsy cores that need to be taken from each magnetic resonance imaging (MRI) region of interest (ROI) to optimize sampling while minimizing overdetection has not yet been clearly elucidated. OBJECTIVE: To characterize the incremental value of additional MRI-ultrasound (US) fusion targeted biopsy cores in defining the optimal number when planning biopsy and to predict men who might benefit from more than two targeted cores. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study of MRI-US fusion targeted biopsies between 2015 and 2017. INTERVENTION: MRI-US fusion targeted biopsy in which four biopsy cores were directed to each MRI-targeted ROI. OUTCOMES MEASUREMENTS AND STATISTICAL ANALYSIS: The MRI-targeted cores representing the first highest Gleason core (FHGC) and first clinically significant cancer core (FCSC; GS≥3+4) were evaluated. We analyzed the frequency of FHGC and FCSC among cores 1-4 and created a logistic regression model to predict FHGC >2. The number of unnecessary cores avoided and the number of malignancies missed for each Gleason grade were calculated via clinical utility analysis. The level of agreement between biopsy and prostatectomy Gleason scores was evaluated using Cohen's κ. RESULTS AND LIMITATIONS: A total of 479 patients underwent fusion targeted biopsy with four individual cores, with 615 ROIs biopsied. Among those, FHGC was core 1 in 477 (76.8%), core 2 in 69 (11.6%), core 3 in 48 (7.6%), and core 4 in 24 men (4.0%) with any cancer. Among men with clinically significant cancer, FCSC was core 1 in 191 (77.8%), core 2 in 26 (11.1%), core 3 in 17 (6.2%), and core 4 in 11 samples (4.9%). In comparison to men with a Prostate Imaging-Reporting and Data System (PI-RADS) score of 5, patients were significantly less likely to have FHGS >2 if they had PI-RADS 4 (odds ratio [OR] 0.287; p=0.006), PI-RADS 3 (OR 0.284; p=0.006), or PI-RADS 2 (OR 0.343; p=0.015). Study limitations include a single-institution experience and the retrospective nature. CONCLUSIONS: Cores 1-2 represented FHGC 88.4% and FCSC 88.9% of the time. A PI-RADS score of 5 independently predicted FHGC >2. Although the majority of cancers in our study were appropriately characterized in the first two biopsy cores, there remains a proportion of men who would benefit from additional cores. PATIENT SUMMARY: In men who undergo magnetic resonance imaging-ultrasound fusion targeted biopsy, the first two biopsy cores diagnose the majority of clinically significant cancers. However, there remains a proportion of men who would benefit from additional cores.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Kenigsberg AP, Renson A, Rosenkrantz AB, et al. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy. Eur Urol Oncol. 2018. PMID: 31158081. doi:10.1016/j.euo.2018.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。